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 A cross-sectional analysis of the Third National Health and 
Nutrition Examination Survey (NHANES III) found that 
overweight children aged between 6 and 16 years had three 
times more asthma risk than their healthy weight peers  (1) . 
Another cross-sectional study supported the relationship 
between asthma and being overweight in childhood and 
showed that the prevalence of asthma was greater in over-
weight children  (2) . 
 Leptin, a 167-amino-acid peptide, is a recently discov-
ered hormone which is believed to play a major role in the 
regulation of body weight. Recently, it has been reported that 
serum leptin levels are increased in asthmatic children  (3) . 
Leptin has also been reported to have a specifi c effect on 
T-lymphocyte responses. It has been hypothesized that lep-
tin is involved in the regulation of asthmatic airway infl am-
mation levels by regulating T-cell responses by polarizing 
Th cells toward a Th1 phenotype and by inhibiting immune 
responses, such as Th2 activation and may have a role in 
asthma  (4) . Mai et al.  (5) found twice as high serum lev-
els of leptin in overweight asthmatic children compared to 
overweight children without current asthma. Serum leptin 
levels are associated with asthma in adult women, indepen-
dent of BMI  (6) . In children with asthma close associations 
have been shown between serum adiponectin and leptin and 
pulmonary function, but it has been suggested that they may 
play a regulatory role rather than being an etiologic mecha-
nism of asthma development  (7) . 
 As very little is known about the role of leptin within the 
airways and lung tissue and asthma, non-invasive tools to 
investigate, such associations would allow epidemiological 
and longitudinal studies to be performed on a larger scale. 
Such studies are needed to confi rm the relationships of leptin 
and asthma and improve our understanding of associations 
between asthma and being overweight. 
 Exhaled breath condensates (EBC) contain aerosolized air-
way lining fl uid and volatile compounds from the airways and 
the lung periphery. The assessment of EBC compounds is rec-
ognized to be a potentially useful research tool in children for 
the non-invasive quantifi cation of airway infl ammation and 
metabolic processes in asthma and other airway diseases. 
 The aim of this pilot study was to evaluate whether leptin 
can be found in EBC and to investigate differences between 
condensate leptin levels in overweight and healthy weight 
children. 
 A total of 20 children (fi ve overweight asthmatics, fi ve 
healthy weight asthmatics, fi ve overweight healthy and fi ve 
healthy weight healthy controls), aged 6 – 15 years, were 
included in this study. We obtained data on weight and length 
(body mass index), lung function, fractional exhaled nitric 
oxide (FE NO ) and allergic sensitization by the means of skin 
prick testing using a panel of common allergens including 
house dust mite, mold mix, tree mix, grass mix, weed mix, cat 
and dog hair. Informed consent was taken from the parents. 
 Exhaled breath condensates were collected using the 
commercial EcoScreen breath condenser system (Jaeger, 
Wuerzburg, Germany). Approximately 1.5 mL of condensate 
was collected in 15 min and immediately stored at  – 70 ° C for 
later analysis. We standardized possible variables during and 
after EBC collection, according to the methodological recom-
mendations of the ATS/ERS task force  (8) . 
 Condensate leptin levels were measured according to the 
instruction by the manufacturer using a commercially available 
ChemoKine TM Human leptin EIA kit (Chemicon International 
Inc., CA, USA) with a lower detection limit of 0.488 ng/mL. 
Leptin levels were measured in un-concentrated, native EBC 
and after concentrating the breath condensate 3-fold by freeze 
drying. 
 The patient characteristics, results of spirometry, FE NO, skin 
prick test and EBC leptin levels are summarized in Table  1 . 
 Leptin levels were below the detection limit of the assay 
(0.488 ng/mL) in the native, un-concentrated EBC and in 
3-fold concentrated samples and were therefore considered as 
non-detectable in any of the EBC samples. 
 We were not able to detect leptin in the EBC from asth-
matic, healthy overweight and healthy weight children, even 
after 3-fold concentration of the EBC samples. We strictly 
followed the methodological recommendations of the ATS/
ERS task force  (8) and the instructions of the manufactur-
ers and standardized possible variables during and after EBC 
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collection. We therefore are confi dent that the non-detectable 
leptin levels in EBC were not due to a collection or measure-
ment error. The assay we used is established for the mea-
surement of leptin in biological fl uids and is not restricted to 
serum. 
 There is still some controversy about the extent of proteins 
in EBC, but it is accepted that they are generally very low 
and often close to the detection limit of the assay used. More 
sensitive and/or specifi c assays, such as radio immunoassay 
or mass spectrometry may allow the measurement of leptin 
within EBC, but levels are expected to be extremely low. 
 A wide range of constituents in EBC have previously been 
measured and the analysis of EBC components has the poten-
tial to provide a non-invasive means of monitoring airway 
infl ammation and cellular metabolism of the lung and air-
ways. However, a range of important methodological issues 
need to be addressed for any EBC compound. These include 
repeatability, dilution, environmental contamination, effects 
of breathing patterns coating of the collector system and assay 
sensitivity  (9, 10) . 
 No leptin was detected in the EBC in native and 3-fold 
concentrated EBC. Exhaled breath condensates are not a use-
ful tool to assess leptin metabolism in overweight and healthy 
weight asthmatic children. 
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 Table 1  Patient characteristics and results of assessments.  
Asthmatics Healthy
Healthy weight Overweight Healthy weight Overweight
n (male/female) 4/1 3/2 4/1 3/2
Age 9.6 ± 3.3 13.2 ± 3.03 12.4 ± 0.8 11.4 ± 2.8
Sensitization  a  5.8 ± 4.0 3.4 ± 3.3 NA NA
BMI, kg/m 2 18.7 ± 3.1 28.2 ± 4.3 17.5 ± 1.9 29.3 ± 6.9
FEV 1 ,  % pred 92.4 ± 15.75 91.6 ± 10.35 90.8 ± 5.4 90.0 ± 13.0
FE NO , ppb 6.3 ± 2.0 12.48 ± 9.39 NA NA
EBC leptin, ng/mL  < 0.488  < 0.488  < 0.488  < 0.488
 All data in mean ± standard deviation. Overweight: BMI-for-age  ≥ 95th percentile. NA, not available.  a Number of allergens. ppb, parts per 
billion. 
